Total Antibody to Infliximab ELISA
Enzyme immunoassay for the semi-quantitative determination of total (free and drug-bound) antibodies to Infliximab (Remicade®, Remsima®) in serum and plasma.
Due to the specific assay design this test measures the antibodies against Infliximab even in a high excess of the drug (up to 20-fold). Results are expressed in tAU (total arbitrary units).
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of total level of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Remicade® is a trademark of Janssen Biotech, Inc./Merck & Co.
Remsima® is a trademark of CellTrion Inc.
The Kit at a glance:
|Required Volume (µL)||20|
|Incubation Time (min)||75|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Results in||Total Arbitrary Units (tAU/mL)|
|Detection Limit (tAU/mL)||10|
|Shelf Life (years)||1|